Back
The Scotts Miracle Gro Vs. Spyre Therapeutics Industry Stock Comparison
Buy
60
SMG
The Scotts Miracle Gro
Last Price:
66.65
Seasonality Move:
0.97%
Sell
27
SYRE
Spyre Therapeutics
Last Price:
23.13
Seasonality Move:
49.76%
Buy
60
The Scotts Miracle Gro (SMG)
is a Buy
Is The Scotts Miracle Gro a Buy, Sell or Hold?
- The current The Scotts Miracle Gro [SMG] share price is $65.87. The Score for SMG is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SMG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SMG Stock Price Chart
What is The Scotts Miracle Gro's stock price today?
-
The The Scotts Miracle Gro share price today is $65.87
The current trend is relatively stagnant and SMG is experiencing slight selling pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
SMG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 46.87 | Sell |
Chaikin Money Flow: | -184298 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.81 - 68.07) | Sell |
Bollinger Bands (100): | (61.45 - 71.47) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 28.27 | Sell |
Chaikin Money Flow: | -408420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.66 - 36.8) | Sell |
Bollinger Bands (100): | (27.1 - 39.22) | Sell |
SMG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.92 | Sell |
20-day SMA: | 66.35 | Sell |
50-day SMA: | 67.53 | Sell |
200-day SMA: | 60.74 | Buy |
8-day EMA: | 66.15 | Sell |
20-day EMA: | 66.53 | Sell |
50-day EMA: | 67.07 | Sell |
200-day EMA: | 64.41 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.49 | Sell |
20-day SMA: | 31.58 | Sell |
50-day SMA: | 33.73 | Sell |
200-day SMA: | 24.46 | Sell |
8-day EMA: | 26.49 | Sell |
20-day EMA: | 30.15 | Sell |
50-day EMA: | 32.53 | Sell |
200-day EMA: | 27.05 | Sell |
The Scotts Miracle Gro Earnings Growth & SMG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $3.44 per share, an increase this year of $1.78 per share, and an increase next year of $1.19 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
The Scotts Miracle Gro Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |